BIIO — Bionovate Technologies Income Statement
0.000.00%
Last trade - 00:00FinancialsHighly SpeculativeMicro Cap
- $0.00m
- $0.19m
Annual income statement for Bionovate Technologies, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2017 June 30th | 2018 June 30th | 2019 June 30th | 2020 June 30th | 2021 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.005 | 0 | 0 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | 0.001 | 0 | — | — | — |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.319 | 1.69 | 0.057 | 0.033 | 0.045 |
| Operating Profit | -0.314 | -1.69 | -0.057 | -0.033 | -0.045 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -0.341 | -1.74 | -0.209 | -0.122 | -0.107 |
| Net Income After Taxes | -0.341 | -1.74 | -0.209 | -0.122 | -0.107 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -0.323 | -1.74 | -0.209 | -0.122 | -0.107 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.323 | -1.74 | -0.209 | -0.122 | -0.107 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -38.3 | -2.7 | -1.34 | -0.005 | -0.002 |